Masayuki Aso

Most-cited papers

1. Ceiling culture-derived proliferative adipocytes retain high adipogenic potential suitable for use as a vehicle for gene transduction therapy.

   Sakiyo Asada, Masayuki Kuroda, Yasuyuki Aoyagi, Y. Fukaya +9 more

   2011American Journal of Physiology - Cell Physiology26 citations

   Semantic Scholar

   Save

2. Ceiling Culture-Derived Proliferative Adipocytes are A Possible Delivery Vehicle for Enzyme Replacement Therapy in Lecithin: Cholesterol Acyltransferase Deficiency

   Masayuki Kuroda, Yasuyuki Aoyagi, Sakiyo Asada, H. Bujo +9 more

   201125 citations Open access

   Semantic Scholar

   Save

3. Fibrin glue increases the cell survival and the transduced gene product secretion of the ceiling culture-derived adipocytes transplanted in mice

   Yasuyuki Aoyagi, Masayuki Kuroda, Sakiyo Asada, H. Bujo +6 more

   2011Experimental and Molecular Medicine23 citations Open access

   Semantic Scholar

   Save

4. Disturbed apolipoprotein A-I-containing lipoproteins in fish-eye disease are improved by the lecithin:cholesterol acyltransferase produced by gene-transduced adipocytes in vitro.

   Sakiyo Asada, Masayuki Kuroda, Yasuyuki Aoyagi, H. Bujo +6 more

   2011Molecular Genetics and Metabolism20 citations

   Semantic Scholar

   Save

5. Fibrin glue is a candidate scaffold for long-term therapeutic protein expression in spontaneously differentiated adipocytes in vitro.

   Yasuyuki Aoyagi, Masayuki Kuroda, Sakiyo Asada, Shigeaki Tanaka +7 more

   2012Experimental Cell Research16 citations

   Semantic Scholar

   Save

6. Adipocytes as a vehicle for ex vivo gene therapy: Novel replacement therapy for diabetes and other metabolic diseases

   Masayuki Kuroda, H. Bujo, Masayuki Aso, Y. Saito

   2011Journal of Diabetes Investigation10 citations Open access

   Semantic Scholar

   Save

7. First-in-human autologous implantation of genetically modified adipocytes expressing LCAT for the treatment of familial LCAT deficiency

   Masayuki Aso, Tokuo T. Yamamoto, Masayuki Kuroda, J. Wada +23 more

   2022Heliyon8 citations Open access

   Semantic Scholar

   Save

8. Utilization of a novel Sendai virus vector in ex vivo gene therapy for hemophilia A

   Y. Yamaki, T. Fukushima, Naomi Yoshida, K. Nishimura +9 more

   2021International journal of hematology7 citations

   Semantic Scholar

   Save

9. A Novel Approach to the Treatment of Plasma Protein Deficiency: Ex Vivo-Manipulated Adipocytes for Sustained Secretion of Therapeutic Proteins.

   Masayuki Kuroda, Y. Saito, Masayuki Aso, K. Yokote

   2018Chemical and pharmaceutical bulletin5 citations Open access

   Semantic Scholar

   Save

10. Gene-manipulated Adipocytes for the Treatment of Various Intractable Diseases.

    Masayuki Kuroda, H. Bujo, Masayuki Aso, Y. Saito +1 more

    2016Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan1 citations Open access

    Semantic Scholar

    Save

11. PS13.4: Autologous transplantation of LCAT gene-transduced adipocytes enabled long-term LCAT replacement in a patient with LCAT deficiency in first in human clinical trial.

    Masayuki Kuroda, Jun Wada, Yoshiro Masezawa, Yoshitaka Kubota +7 more

    2025Transplantation0 citations

    Semantic Scholar

    Save

12. First-in-Human Autologous Implantation of Genetically Modified Adipocytes Expressing LCAT for the Treatment of Familial LCAT Deficiency

    Masayuki Aso, Tokuo Yamamoto, Masayuki Kuroda, Jun Wada +22 more

    2021Social Science Research Network0 citations

    Semantic Scholar

    Save

13. Ex Vivo Gene-manipulated Mature Adipocytes: Novel Gene Therapy Medicine for Sustained Protein Replacement Therapy of Variety of Intractable Diseases

    Masayuki Kuroda, Bujo Hideaki, Yokote Koutaro, Yasushi Saito +1 more

    20170 citations

    Semantic Scholar

    Save